Phase II TORTUGA trial of filgotinib in ankylosing spondylitis meets primary efficacy endpoint Sep. 6, 2018
Phase III study of NeoCart in patients with knee cartilage damage does not meet the primary endpoint Sep. 6, 2018
Fasinumab topline phase III data presented in patients with chronic pain from OA of the knee or hip Aug. 17, 2018
RSS